A reproducible index of liquid-biopsy innovation from 1960 to 2026: the shape of the field by application area, the patents behind it and the clinical trials testing it. Every number traces back to a source record.
Tracks
Research
40,475 in-scope papers, 1960 to 2026. Year-over-year growth decomposed by application area, analyte, geography, and impact.
Patents
10,884 in-scope granted inventions, de-duplicated by patent family, in a US-anchored landscape plus a separate China-only view, with 1,366 still-pending US applications alongside.
Clinical Trials
4,302 registered trials whose registrations describe liquid-biopsy work, classified by what each asks of the test: a test trial, a treatment selection trial, an eligibility selection trial, or a correlative study trial.
Profiles
Companies
A searchable directory of every company developing a liquid-biopsy test, each with a dossier of its research footprint by indication, use, and impact, its patents, and the clinical trials it sponsors or collaborates on.
SubscribersInstitutions
The universities, hospitals and research institutes behind the field, each with a profile of its published research, the inventions it owns, and the clinical trials it sponsors or collaborates on.
SubscribersAuthors
The researchers behind the field, ranked by first- and last-author papers, each with a profile of their attributed work and the affiliations printed on it.
SubscribersJournals
The journals that publish liquid-biopsy research, each with a profile of what it publishes in the field and when.
SubscribersExplore And Methods
New to liquid biopsy? The Learn pages explain what these tests look for, what they are used for, and what each approach can and cannot do. They assume no background.
Start with the basics →